EP Patent

EP0625162B1 — Methods of producing analgesia and enhancing opiate analgesia

Assigned to Eisai R&D Management Co Ltd · Expires 1998-05-13 · 28y expired

What this patent protects

Disclosed are novel omega conotoxin peptides effective in producing analgesia.

USPTO Abstract

Disclosed are novel omega conotoxin peptides effective in producing analgesia.

Drugs covered by this patent

tenapanor-hydrochloride (TENAPANOR HYDROCHLORIDE)

Patent Metadata

Patent number: EP0625162B1
Jurisdiction: EP
Classification: —
Expires: 1998-05-13
Drug substance claim: No
Drug product claim: No
Assignee: Eisai R&D Management Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.